TG Therapeutics Investigational Site — Louisville, Kentucky

TG Therapeutics Investigational Site is a clinical research site located in Louisville, Kentucky, United States 40207.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

TG Therapeutics Investigational Site has participated in 1 clinical trials.

Therapeutic areas: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma.

Sponsors: TG Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for TG Therapeutics Investigational Site?

TG Therapeutics Investigational Site has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has TG Therapeutics Investigational Site conducted?

TG Therapeutics Investigational Site has 1 clinical trials on record. Their work covers Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma.

Is TG Therapeutics Investigational Site accredited by Crixeo Health?

TG Therapeutics Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about TG Therapeutics Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.